A hot flush is easy to dismiss until you have had one in a meeting: a surge of heat rising through the chest, neck and face, skin flushing, sweat arriving with a soundtrack of a racing heart, then a chill as it recedes, all inside a few minutes and entirely indifferent to context. Around three quarters of women experience them across the menopause transition, at a median duration of over seven years, and night-time versions fragment sleep with a thoroughness that colours everything downstream. They are also among the most treatable symptoms in the whole of midlife medicine, which makes the amount of unassisted suffering around them genuinely unnecessary. What follows is the mechanism, then the treatment list in honest order of effectiveness, from the benchmark downwards.
What is actually happening
The hypothalamus runs the body's thermostat, holding core temperature inside a neutral zone within which no corrective action is needed. Falling and fluctuating oestrogen narrows that zone dramatically, partly through its effect on a group of brain cells called KNDy neurons, so temperature shifts the body once ignored now trip the alarm. The brain responds as though you are overheating: blood vessels in the skin dilate to dump heat, sweat glands fire, the heart speeds up. That is the flush. The chill afterwards is the overshoot. Understanding this mechanism matters because it explains both ends of the treatment list: restore oestrogen and the zone widens again; and the newest non-hormonal medicines target those same KNDy pathways directly.
HRT: the benchmark treatment
Hormone replacement therapy is the most effective treatment for vasomotor symptoms, reducing flush frequency by roughly 75% in trials and softening the severity of those that remain. Modern practice favours transdermal oestrogen, patches, gels or sprays, which avoids the clot risk associated with tablets, paired with micronised progesterone for anyone with a womb. For most healthy women starting under 60 or within ten years of menopause, UK guidance is unambiguous that benefits outweigh risks, and improvement usually arrives within weeks. HRT is not suitable for everyone; a history of hormone-sensitive breast cancer is the main exclusion, and personal risk always deserves a proper consultation rather than a blanket rule. But the cultural residue of the 2002 scare still keeps eligible women away from the single most effective option, often for decades of symptomatic years, and correcting that miscalibration probably relieves more midlife suffering than any other sentence in this article.
Effective options without hormones
For women who cannot or prefer not to take HRT, the evidence-backed shelf is better stocked than it used to be. Newer medicines targeting the KNDy pathway directly, the neurokinin-3 receptor antagonists such as fezolinetant, reduce flush frequency substantially in trials and are reaching UK practice for exactly this indication. Certain antidepressants at low dose, including venlafaxine and some SSRIs, cut flushes meaningfully, with the caveat that paroxetine and fluoxetine should be avoided by women taking tamoxifen because of drug interactions. Gabapentin helps some women, particularly with night sweats, though drowsiness limits it for others. Cognitive behavioural therapy has good trial evidence: it does not switch flushes off, but it reliably reduces how much they bother and disrupt, improves sleep and quality of life, and NICE recommends it, including in self-help formats designed for menopause. Clinical hypnosis has more supportive data than most people expect. What unites the list is that each option is a real clinical decision with dosing and trade-offs, which is to say a conversation with a prescriber, not a supermarket shelf.
Lifestyle levers: modest, immediate, worth pulling
No lifestyle change matches medication, but several stack useful percentages. Identify personal triggers honestly for a fortnight: alcohol, caffeine, spicy food, hot drinks, stress spikes and warm rooms are the recurring offenders, and alcohol is the one whose removal most often surprises people with its effect size. Dress in sheddable layers and favour natural fibres. Smoking is associated with more frequent and severe flushes, one more entry on its charge sheet. Weight loss helps in women carrying extra weight, with trial support. Regular exercise improves sleep, mood and cardiovascular health across the transition, even where its direct effect on flush counts is equivocal. Paced breathing during a flush, slow and diaphragmatic, will not abort it but reliably shrinks the panic that amplifies it. None of this is transformative alone; together it lowers the baseline the flushes are working from.
The supplement aisle, audited
The market for flush remedies is large and mostly disappointing under trial conditions. Black cohosh shows inconsistent results across studies and carries rare liver warnings; red clover and soya isoflavones perform marginally better than placebo in some analyses and identically in others, with a question mark for women advised to avoid oestrogenic compounds; evening primrose oil has repeatedly failed to beat placebo; and magnet devices deserve their place in history's curiosity drawer. The placebo response in flush trials runs high, around 30%, which is why testimonials abound for everything. Money aimed at this problem buys more relief through a prescriber's appointment than through the supplement aisle, and any woman taking tamoxifen or with a cancer history should treat botanical oestrogens as a clinical question, not a checkout impulse. The honest hierarchy stands: HRT first where suitable, evidence-backed non-hormonal medicines and CBT where not, lifestyle levers underneath everything, and scepticism at the checkout. For where flushes sit in the broader transition, see our guides to perimenopause symptoms and how long menopause lasts.
